Kiyoko Yamada

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Ejection Fraction

Top Venues

The Journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Kiyoko Yamada, Atsunori Baba, Takuro Kanekura
A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Kiyoko Yamada, Atsunori Baba, Takuro Kanekura
A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Atsunori Baba, Kiyoko Yamada, Takuro Kanekura
Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies. The Journal of dermatology 51 (6) (2024)
Atsunori Baba, Kiyoko Yamada, Takuro Kanekura
Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies. The Journal of dermatology 51 (6) (2024)
Atsunori Baba, Kiyoko Yamada, Takuro Kanekura
Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies. The Journal of dermatology 51 (6) (2024)
Atsunori Baba, Kiyoko Yamada, Takuro Kanekura
Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies. The Journal of dermatology (2024)
Kiyoko Yamada, Atsunori Baba, Takuro Kanekura
A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)